$ci 2024 Q3 10-Q

Concept	2024 Q3	2024 Q2
Revenue		$60.52B
YoY Change		24.57%
Cost Of Revenue		$44.49B
YoY Change		4.75%
Gross Profit		$16.03B
YoY Change		162.37%
Gross Profit Margin		26.49%
Selling, General & Admin		$3.684B
YoY Change		7.28%
% of Gross Profit		22.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$738.0M
YoY Change		-2.25%
% of Gross Profit		4.6%
Operating Expenses		$3.684B
YoY Change		-5.27%
Operating Profit		$2.412B
YoY Change		8.6%
Interest Expense		-$423.0M
YoY Change		25.52%
% of Operating Profit		-17.54%
Other Income/Expense, Net		-$375.0M
YoY Change		3.31%
Pretax Income		$1.989B
YoY Change		5.57%
Income Tax		$360.0M
% Of Pretax Income		18.1%
Net Earnings		$1.629B
YoY Change		11.58%
Net Earnings / Revenue		2.69%
Basic Earnings Per Share		$5.51
Diluted Earnings Per Share		$5.45
COMMON SHARES
Basic Shares Outstanding	279.5M shares	284.1M shares
Diluted Shares Outstanding		284.1M shares

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$7.856B
YoY Change		-24.87%
Cash & Equivalents		$6.788B
Short-Term Investments		$1.068B
Other Short-Term Assets		$2.664B
YoY Change		89.34%
Inventory		$5.173B
Prepaid Expenses
Receivables		$25.11B
Other Receivables		$0.00
Total Short-Term Assets		$46.22B
YoY Change		33.14%
LONG-TERM ASSETS
Property, Plant & Equipment		$3.551B
YoY Change		-8.57%
Goodwill		$44.26B
YoY Change		-3.39%
Intangibles		$30.18B
YoY Change		-4.85%
Long-Term Investments		$15.94B
YoY Change		-15.94%
Other Assets		$3.276B
YoY Change		-78.11%
Total Long-Term Assets		$109.2B
YoY Change		-5.3%
TOTAL ASSETS
Total Short-Term Assets		$46.22B
Total Long-Term Assets		$109.2B
Total Assets		$155.4B
YoY Change		3.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$9.275B
YoY Change		14.9%
Accrued Expenses		$9.003B
YoY Change		5.93%
Deferred Revenue
YoY Change
Short-Term Debt		$790.0M
YoY Change
Long-Term Debt Due		$927.0M
YoY Change		-79.93%
Total Short-Term Liabilities		$55.37B
YoY Change		16.96%
LONG-TERM LIABILITIES
Long-Term Debt		$30.18B
YoY Change		7.33%
Other Long-Term Liabilities		$3.538B
YoY Change		-83.52%
Total Long-Term Liabilities		$3.538B
YoY Change		-92.87%
TOTAL LIABILITIES
Total Short-Term Liabilities		$55.37B
Total Long-Term Liabilities		$3.538B
Total Liabilities		$113.9B
YoY Change		8.9%
SHAREHOLDERS EQUITY
Retained Earnings		$42.13B
YoY Change		5.5%
Common Stock		$31.05B
YoY Change		2.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$29.41B
YoY Change		27.58%
Treasury Stock Shares
Shareholders Equity		$41.33B
YoY Change
Total Liabilities & Shareholders Equity		$155.4B
YoY Change		3.59%

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income		$1.629B
YoY Change		11.58%
Depreciation, Depletion And Amortization		$738.0M
YoY Change		-2.25%
Cash From Operating Activities		$265.0M
YoY Change		-89.37%
INVESTING ACTIVITIES
Capital Expenditures		$370.0M
YoY Change		-6.8%
Acquisitions
YoY Change
Other Investing Activities		-$270.0M
YoY Change		1488.24%
Cash From Investing Activities		-$640.0M
YoY Change		54.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-2.309B
YoY Change		430.8%
NET CHANGE
Cash From Operating Activities		265.0M
Cash From Investing Activities		-640.0M
Cash From Financing Activities		-2.309B
Net Change In Cash		-2.684B
YoY Change		-263.36%
FREE CASH FLOW
Cash From Operating Activities		$265.0M
Capital Expenditures		$370.0M
Free Cash Flow		-$105.0M
YoY Change		-105.01%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4991898
	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Cottage Grove Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bloomfield
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06002
	dei	City Area Code CityAreaCode	860
	dei	Local Phone Number LocalPhoneNumber	226-6000
	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.01
	dei	Trading Symbol TradingSymbol	CI
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	279548797	shares
CY2024Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	11454000000	usd
CY2023Q2	us-gaap	Premiums Earned Net PremiumsEarnedNet	11039000000	usd
	us-gaap	Premiums Earned Net PremiumsEarnedNet	23057000000	usd
	us-gaap	Premiums Earned Net PremiumsEarnedNet	22064000000	usd
CY2024Q2	us-gaap	Net Investment Income NetInvestmentIncome	321000000	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	278000000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	611000000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	555000000	usd
CY2024Q2	us-gaap	Revenues Revenues	60523000000	usd
CY2023Q2	us-gaap	Revenues Revenues	48586000000	usd
	us-gaap	Revenues Revenues	117778000000	usd
	us-gaap	Revenues Revenues	95103000000	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44492000000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	64901000000	usd
CY2024Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	9515000000	usd
CY2023Q2	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	9034000000	usd
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	18955000000	usd
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	18080000000	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3684000000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2412000000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2221000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	4668000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	4236000000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	50000000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	146000000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	89000000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1430000000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	693000000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2507000000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6788000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7822000000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	1068000000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	925000000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	25111000000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17722000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	5173000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	5645000000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2664000000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2169000000	usd
CY2023Q2	ci	Non Investment Revenue NonInvestmentRevenue	48308000000	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	278000000	usd
CY2023Q2	us-gaap	Revenues Revenues	48586000000	usd
CY2023Q2	ci	Realized Investment Gains Losses Equity Method Investments RealizedInvestmentGainsLossesEquityMethodInvestments	-30000000	usd
CY2023Q2	ci	Segment Revenues SegmentRevenues	48616000000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1884000000	usd
CY2023Q2	ci	Income Loss Attributable To Noncontrolling Interest Before Tax IncomeLossAttributableToNoncontrollingInterestBeforeTax	55000000	usd
CY2023Q2	ci	Realized Investment Gain Loss Including Equity Method Subsidiaries RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries	-4000000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	455000000	usd
CY2023Q2	ci	Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2294000000	usd
	ci	Non Investment Revenue NonInvestmentRevenue	117167000000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	611000000	usd
	us-gaap	Revenues Revenues	117778000000	usd
	ci	Realized Investment Gains Losses Equity Method Investments RealizedInvestmentGainsLossesEquityMethodInvestments	61000000	usd
	ci	Segment Revenues SegmentRevenues	117717000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2068000000	usd
	ci	Income Loss Attributable To Noncontrolling Interest Before Tax IncomeLossAttributableToNoncontrollingInterestBeforeTax	172000000	usd
	ci	Realized Investment Gain Loss Including Equity Method Subsidiaries RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries	-1823000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	843000000	usd
	ci	Transaction Related Costs TransactionRelatedCosts	100000000	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33442000000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	85923000000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3434000000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7389000000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	420000000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	455000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	843000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	914000000	usd
CY2024Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	58111000000	usd
CY2023Q2	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	46365000000	usd
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	113110000000	usd
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	90867000000	usd
CY2024Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-19000000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2024Q2	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	-48000000	usd
CY2023Q2	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	26000000	usd
	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	-1884000000	usd
	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	-30000000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1989000000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1884000000	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.15
CY2024Q2	us-gaap	Profit Loss ProfitLoss	1629000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	1510000000	usd
	us-gaap	Profit Loss ProfitLoss	1417000000	usd
	us-gaap	Profit Loss ProfitLoss	2816000000	usd
CY2024Q2	ci	Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax	108000000	usd
CY2023Q2	ci	Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax	20000000	usd
	ci	Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax	229000000	usd
	ci	Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax	214000000	usd
CY2024Q2	ci	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity	-5000000	usd
CY2023Q2	ci	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity	-19000000	usd
	ci	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity	-31000000	usd
	ci	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity	-3000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	9000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-7000000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	4000000	usd
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-17000000	usd
CY2024Q2	ci	Other Comprehensive Income Loss Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity	-118000000	usd
CY2023Q2	ci	Other Comprehensive Income Loss Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity	-109000000	usd
	ci	Other Comprehensive Income Loss Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity	-578000000	usd
	ci	Other Comprehensive Income Loss Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity	-220000000	usd
CY2024Q2	ci	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity	1511000000	usd
CY2023Q2	ci	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity	1401000000	usd
	ci	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity	839000000	usd
	ci	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity	2596000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	45000000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	79000000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	5000000	usd
	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	146000000	usd
	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	10000000	usd
CY2024Q2	us-gaap	Assets Assets	155446000000	usd
CY2023Q4	us-gaap	Assets Assets	152761000000	usd
CY2024Q2	ci	Insurance And Contractholder Liabilities Current InsuranceAndContractholderLiabilitiesCurrent	5616000000	usd
CY2023Q4	ci	Insurance And Contractholder Liabilities Current InsuranceAndContractholderLiabilitiesCurrent	5514000000	usd
CY2024Q2	ci	Pharmacy And Service Costs Payable PharmacyAndServiceCostsPayable	27503000000	usd
CY2024Q2	us-gaap	Debt Current DebtCurrent	1717000000	usd
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2919000	shares
	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	76000000	usd
	ci	Transaction Related Costs TransactionRelatedCosts	7000000	usd
	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	6000000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1460000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	281133000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2367000	shares
CY2024Q2	us-gaap	Debt Current DebtCurrent	1717000000	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	378000000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	747000000	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001739940
CY2023Q4	ci	Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Sold That Remain Outstanding AccountsReceivableUncommittedFactoringFacilityAccountsReceivableSoldThatRemainOutstanding	0	usd
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#AccountsPayableCurrent
CY2024Q2	us-gaap	Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2024#AccountsPayableCurrent
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax		usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax		usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax		usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax		usd
CY2024Q2	ci	Impairments Requiring Certain Assets And Liabiliaties To Be Measured At Fair Value ImpairmentsRequiringCertainAssetsAndLiabiliatiesToBeMeasuredAtFairValue		usd
	ci	Impairments Requiring Certain Assets And Liabiliaties To Be Measured At Fair Value ImpairmentsRequiringCertainAssetsAndLiabiliatiesToBeMeasuredAtFairValue		usd
CY2024Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount		usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount		usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount		usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount		usd
CY2024Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount		usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount		usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount		usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount		usd
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38769
	dei	Entity Registrant Name EntityRegistrantName	The Cigna Group
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6972000000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-375000000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-363000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-697000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-721000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2068000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3485000000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	360000000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	374000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	651000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	669000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	1629000000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	1510000000	usd
	us-gaap	Profit Loss ProfitLoss	1417000000	usd
	us-gaap	Profit Loss ProfitLoss	2816000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	81000000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	50000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	146000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	89000000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1548000000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1460000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1271000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2727000000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.51
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.96
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.24
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.45
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.92
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.43
CY2024Q2	ci	Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent	-212000000	usd
CY2023Q2	ci	Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent	-117000000	usd
	ci	Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent	-772000000	usd
	ci	Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent	-448000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	81000000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	81000000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1351000000	usd
CY2024Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	5411000000	usd
CY2023Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3068000000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	46215000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	37351000000	usd
CY2024Q2	us-gaap	Long Term Investments LongTermInvestments	15944000000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	17985000000	usd
CY2024Q2	ci	Reinsurance Recoverables Non Current ReinsuranceRecoverablesNonCurrent	4595000000	usd
CY2023Q4	ci	Reinsurance Recoverables Non Current ReinsuranceRecoverablesNonCurrent	4835000000	usd
CY2024Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	3551000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	3695000000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	44258000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	44259000000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30176000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30863000000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3276000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3421000000	usd
CY2024Q2	us-gaap	Separate Account Assets SeparateAccountAssets	7431000000	usd
CY2023Q4	us-gaap	Separate Account Assets SeparateAccountAssets	7430000000	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	2922000000	usd
CY2023Q4	ci	Pharmacy And Service Costs Payable PharmacyAndServiceCostsPayable	19815000000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9275000000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8553000000	usd
CY2024Q2	ci	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	9003000000	usd
CY2023Q4	ci	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	9955000000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	2775000000	usd
CY2024Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2259000000	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2104000000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	55373000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	48716000000	usd
CY2024Q2	ci	Insurance And Contractholder Liabilities Noncurrent InsuranceAndContractholderLiabilitiesNoncurrent	10449000000	usd
CY2023Q4	ci	Insurance And Contractholder Liabilities Noncurrent InsuranceAndContractholderLiabilitiesNoncurrent	10904000000	usd
CY2024Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6953000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7173000000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3538000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3441000000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	30175000000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	28155000000	usd
CY2024Q2	us-gaap	Separate Accounts Liability SeparateAccountsLiability	7431000000	usd
CY2023Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	7430000000	usd
CY2024Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	usd
CY2023Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	591000000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	113919000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	106410000000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	107000000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	4000000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	31048000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	30669000000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2442000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1864000000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	42132000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	41652000000	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	29410000000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	24238000000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	41332000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	46223000000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	195000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	21000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41527000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46244000000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	155446000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	152761000000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	402000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	400000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41350000000	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	115000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-118000000	usd
CY2024Q2	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	0	usd
CY2024Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	1629000000	usd
CY2024Q2	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	0	usd
CY2024Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.40
CY2024Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	394000000	usd
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1000000000	usd
CY2024Q2	ci	Noncontrolling Interest Other Changes NoncontrollingInterestOtherChanges	-55000000	usd
CY2024Q2	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	0	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41527000000	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44518000000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	78000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	105000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-109000000	usd
CY2023Q2	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	0	usd
CY2023Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	1465000000	usd
CY2023Q2	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	45000000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.23
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	365000000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	146000000	usd
CY2023Q2	ci	Noncontrolling Interest Other Changes NoncontrollingInterestOtherChanges	-4000000	usd
CY2023Q2	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-61000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	45464000000	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	62000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46244000000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	107000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	264000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-578000000	usd
	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	0	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	1417000000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	0	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.80
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	791000000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5057000000	usd
	ci	Noncontrolling Interest Other Changes NoncontrollingInterestOtherChanges	28000000	usd
	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-107000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41527000000	usd
CY2024Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44688000000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	66000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-220000000	usd
	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	0	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	2737000000	usd
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	79000000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.46
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	731000000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1104000000	usd
	ci	Noncontrolling Interest Other Changes NoncontrollingInterestOtherChanges	-6000000	usd
	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-83000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	45464000000	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	62000000	usd
	us-gaap	Profit Loss ProfitLoss	1417000000	usd
	us-gaap	Profit Loss ProfitLoss	2816000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1479000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1504000000	usd
	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	-1884000000	usd
	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	-30000000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	199000000	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	207000000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-19000000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	7313000000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1144000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-472000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-263000000	usd
	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	559000000	usd
	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-109000000	usd
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-125000000	usd
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	1727000000	usd
	ci	Increase Decrease In Pharmacy And Service Costs Payable IncreaseDecreaseInPharmacyAndServiceCostsPayable	7820000000	usd
	ci	Increase Decrease In Pharmacy And Service Costs Payable IncreaseDecreaseInPharmacyAndServiceCostsPayable	1547000000	usd
	ci	Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities	-15000000	usd
	ci	Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities	638000000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-225000000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-237000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5105000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7520000000	usd
	ci	Proceeds From Sale Of Debt And Equity Securities ProceedsFromSaleOfDebtAndEquitySecurities	393000000	usd
	ci	Proceeds From Sale Of Debt And Equity Securities ProceedsFromSaleOfDebtAndEquitySecurities	646000000	usd
	ci	Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities	414000000	usd
	ci	Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities	502000000	usd
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	37000000	usd
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	82000000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	451000000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	313000000	usd
	ci	Payments To Acquire Debt And Equity Securities PaymentsToAcquireDebtAndEquitySecurities	493000000	usd
	ci	Payments To Acquire Debt And Equity Securities PaymentsToAcquireDebtAndEquitySecurities	3339000000	usd
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	52000000	usd
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	59000000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	865000000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	685000000	usd
	ci	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	670000000	usd
	ci	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	805000000	usd
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	usd
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	27000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	350000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	79000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1135000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3397000000	usd
	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	84000000	usd
	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	96000000	usd
	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	135000000	usd
	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	100000000	usd
	ci	Proceeds From Repayments Of Other Short Term Debt ProceedsFromRepaymentsOfOtherShortTermDebt	-467000000	usd
	ci	Proceeds From Repayments Of Other Short Term Debt ProceedsFromRepaymentsOfOtherShortTermDebt	183000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3000000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	80000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4462000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1491000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5012000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1116000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	221000000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	59000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	793000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	730000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-198000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-275000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4838000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-472000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-12000000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-880000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3660000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8337000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5976000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7457000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9636000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	625000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	0	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6832000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9636000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	567000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	926000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	643000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	632000000	usd
	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-bottom:10pt"><span id="id99bd35dae21465297a1d2fbd4eff826_4265"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 – Description of Business</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future for every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. Powered by our people and our brands, we advance our mission to improve the health and vitality of those we serve. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. The majority of these products and services are offered through employers and other entities such as governmental and non-governmental organizations, unions and associations. Cigna Healthcare also offers health and dental insurance and Medicare products to individuals in the United States and select international markets. In addition to these operations, The Cigna Group also has certain run-off operations.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A full description of our segments follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Evernorth Health Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reportable segment includes the Pharmacy Benefit Services and the Specialty and Care Services operating segments, which partner with health plans, employers, governmental organizations and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pharmacy Benefit Services drives high-quality, cost-effective pharmacy care through various services such as drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person health outcomes through Care Delivery and Management Solutions. The Company's reporting units remain aligned with its operating segments and Evernorth Health Services' goodwill was allocated on a relative fair value basis.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cigna Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> reportable segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Healthcare provides medical plans and specialty benefits and solutions for insured and self-insured clients, Medicare Advantage, Medicare Supplement and Medicare Stand-Alone Prescription Drug Plans for seniors and individual health insurance plans. International Health provides health care solutions in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In January 2024, the Company entered into a definitive agreement to sell the Medicare Advantage, Medicare Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits and CareAllies businesses within the <span style="-sec-ix-hidden:f-508">U.S. Healthcare</span> operating segment to Health Care Service Corporation ("HCSC") for approximately $3.3 billion cash, subject to applicable regulatory approvals and other customary closing conditions (the "HCSC transaction"). See Note 5 to the Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> comprises the remainder of our business operations, which includes our continuing business (corporate-owned life insurance ("COLI")) and our run-off and other non-strategic businesses. Our run-off businesses include (i) variable annuity reinsurance business that was effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013, (ii) settlement annuity business, and (iii) individual life insurance and annuity and retirement benefits businesses which were sold through reinsurance agreements.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate financing less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and eliminations for products and services sold between segments.</span></div>
CY2024Q2	ci	Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale	12555000000	usd
CY2023Q4	ci	Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale	8169000000	usd
CY2024Q2	ci	Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale	10946000000	usd
CY2023Q4	ci	Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale	8044000000	usd
CY2024Q2	ci	Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale	2325000000	usd
CY2023Q4	ci	Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale	2359000000	usd
CY2024Q2	ci	Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale	289000000	usd
CY2023Q4	ci	Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale	272000000	usd
CY2024Q2	ci	Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale	26115000000	usd
CY2023Q4	ci	Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale	18844000000	usd
CY2024Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	25111000000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	17722000000	usd
CY2024Q2	ci	Allowance For Receivables Current AllowanceForReceivablesCurrent	4400000000	usd
CY2023Q4	ci	Allowance For Receivables Current AllowanceForReceivablesCurrent	3700000000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	95000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	90000000	usd
CY2023Q3	ci	Accounts Receivable Uncommitted Factoring Facility Initial Term AccountsReceivableUncommittedFactoringFacilityInitialTerm	P2Y
CY2023Q3	ci	Accounts Receivable Uncommitted Factoring Facility Automatic Renewal Term AccountsReceivableUncommittedFactoringFacilityAutomaticRenewalTerm	P1Y
CY2023Q3	ci	Accounts Receivable Uncommitted Factoring Facility Total Capacity AccountsReceivableUncommittedFactoringFacilityTotalCapacity	1000000000.0	usd
CY2024Q2	ci	Accounts Receivable Uncommitted Factoring Facility Total Capacity AccountsReceivableUncommittedFactoringFacilityTotalCapacity	1500000000	usd
CY2024Q2	ci	Accounts Receivable Uncommitted Factoring Facility Amount Sold AccountsReceivableUncommittedFactoringFacilityAmountSold	1300000000	usd
	ci	Accounts Receivable Uncommitted Factoring Facility Amount Sold AccountsReceivableUncommittedFactoringFacilityAmountSold	3200000000	usd
CY2024Q2	ci	Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Sold That Remain Outstanding AccountsReceivableUncommittedFactoringFacilityAccountsReceivableSoldThatRemainOutstanding	322000000	usd
CY2024Q2	ci	Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted	713000000	usd
CY2023Q4	ci	Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted	515000000	usd
CY2024Q2	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	1700000000	usd
CY2023Q4	us-gaap	Supplier Finance Program Obligation Current SupplierFinanceProgramObligationCurrent	1500000000	usd
CY2024Q2	ci	Supplier Finance Program Outstanding Payment Obligation Current Voluntarily Elected To Be Sold SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold	348000000	usd
CY2024Q2	ci	Transaction Related Costs TransactionRelatedCosts	63000000	usd
CY2024Q2	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	47000000	usd
	ci	Transaction Related Costs TransactionRelatedCosts	100000000	usd
	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	76000000	usd
CY2023Q2	ci	Transaction Related Costs TransactionRelatedCosts	6000000	usd
CY2023Q2	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	5000000	usd
	ci	Transaction Related Costs TransactionRelatedCosts	7000000	usd
	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	6000000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1548000000	usd
CY2024Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1548000000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1460000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	281133000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	281133000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	294512000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	294512000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2919000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2367000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2367000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2919000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	284052000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	294512000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	296879000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.51
CY2024Q2	ci	Earnings Per Share Effect Of Dilution EarningsPerShareEffectOfDilution	-0.06
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.45
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.96
CY2023Q2	ci	Earnings Per Share Effect Of Dilution EarningsPerShareEffectOfDilution	-0.04
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.92
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1271000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1271000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2727000000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2727000000	usd
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	283799000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	283799000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	295105000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	295105000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3085000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3085000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2831000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2831000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	283799000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3085000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	286884000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	295105000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2831000	shares

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2024

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

dei

Amendment Flag

AmendmentFlag

false

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

82-4991898

dei

Entity Address Address Line1

EntityAddressAddressLine1

900 Cottage Grove Road

dei

Entity Address City Or Town

EntityAddressCityOrTown

Bloomfield

dei

Entity Address State Or Province

EntityAddressStateOrProvince

CT

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

06002

dei

City Area Code

CityAreaCode

860

dei

Local Phone Number

LocalPhoneNumber

226-6000

dei

Security12b Title

Security12bTitle

Common Stock, Par Value $0.01

dei

Trading Symbol

TradingSymbol

CI

dei

Security Exchange Name

SecurityExchangeName

NYSE

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

dei

Entity Small Business

EntitySmallBusiness

false

dei

Entity Shell Company

EntityShellCompany

false

CY2024Q3

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

279548797

shares

CY2024Q2

us-gaap

Premiums Earned Net

PremiumsEarnedNet

11454000000

usd

CY2023Q2

us-gaap

Premiums Earned Net

PremiumsEarnedNet

11039000000

usd

us-gaap

Premiums Earned Net

PremiumsEarnedNet

23057000000

usd

us-gaap

Premiums Earned Net

PremiumsEarnedNet

22064000000

usd

CY2024Q2

us-gaap

Net Investment Income

NetInvestmentIncome

321000000

usd

CY2023Q2

us-gaap

Net Investment Income

NetInvestmentIncome

278000000

usd

us-gaap

Net Investment Income

NetInvestmentIncome

611000000

usd

us-gaap

Net Investment Income

NetInvestmentIncome

555000000

usd

CY2024Q2

us-gaap

Revenues

60523000000

usd

CY2023Q2

us-gaap

Revenues

48586000000

usd

us-gaap

Revenues

117778000000

usd

us-gaap

Revenues

95103000000

usd

CY2024Q2

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

44492000000

usd

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

64901000000

usd

CY2024Q2

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

9515000000

usd

CY2023Q2

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

9034000000

usd

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

18955000000

usd

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

18080000000

usd

CY2024Q2

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

3684000000

usd

CY2024Q2

us-gaap

Operating Income Loss

OperatingIncomeLoss

2412000000

usd

CY2023Q2

us-gaap

Operating Income Loss

OperatingIncomeLoss

2221000000

usd

us-gaap

Operating Income Loss

OperatingIncomeLoss

4668000000

usd

us-gaap

Operating Income Loss

OperatingIncomeLoss

4236000000

usd

CY2023Q2

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

50000000

usd

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

146000000

usd

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

89000000

usd

CY2024Q2

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

1430000000

usd

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

693000000

usd

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

2507000000

usd

CY2024Q2

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

6788000000

usd

CY2023Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

7822000000

usd

CY2024Q2

us-gaap

Short Term Investments

ShortTermInvestments

1068000000

usd

CY2023Q4

us-gaap

Short Term Investments

ShortTermInvestments

925000000

usd

CY2024Q2

us-gaap

Receivables Net Current

ReceivablesNetCurrent

25111000000

usd

CY2023Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

17722000000

usd

CY2024Q2

us-gaap

Inventory Net

InventoryNet

5173000000

usd

CY2023Q4

us-gaap

Inventory Net

InventoryNet

5645000000

usd

CY2024Q2

us-gaap

Other Assets Current

OtherAssetsCurrent

2664000000

usd

CY2023Q4

us-gaap

Other Assets Current

OtherAssetsCurrent

2169000000

usd

CY2023Q2

ci

Non Investment Revenue

NonInvestmentRevenue

48308000000

usd

CY2023Q2

us-gaap

Net Investment Income

NetInvestmentIncome

278000000

usd

CY2023Q2

us-gaap

Revenues

48586000000

usd

CY2023Q2

ci

Realized Investment Gains Losses Equity Method Investments

RealizedInvestmentGainsLossesEquityMethodInvestments

-30000000

usd

CY2023Q2

ci

Segment Revenues

SegmentRevenues

48616000000

usd

CY2023Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

1884000000

usd

CY2023Q2

ci

Income Loss Attributable To Noncontrolling Interest Before Tax

IncomeLossAttributableToNoncontrollingInterestBeforeTax

55000000

usd

CY2023Q2

ci

Realized Investment Gain Loss Including Equity Method Subsidiaries

RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries

-4000000

usd

CY2023Q2

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

455000000

usd

CY2023Q2

ci

Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

2294000000

usd

ci

Non Investment Revenue

NonInvestmentRevenue

117167000000

usd

us-gaap

Net Investment Income

NetInvestmentIncome

611000000

usd

us-gaap

Revenues

117778000000

usd

ci

Realized Investment Gains Losses Equity Method Investments

RealizedInvestmentGainsLossesEquityMethodInvestments

61000000

usd

ci

Segment Revenues

SegmentRevenues

117717000000

usd

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

2068000000

usd

ci

Income Loss Attributable To Noncontrolling Interest Before Tax

IncomeLossAttributableToNoncontrollingInterestBeforeTax

172000000

usd

ci

Realized Investment Gain Loss Including Equity Method Subsidiaries

RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries

-1823000000

usd

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

843000000

usd

ci

Transaction Related Costs

TransactionRelatedCosts

100000000

usd

dei

Document Type

DocumentType

10-Q

dei

Document Quarterly Report

DocumentQuarterlyReport

true

CY2023Q2

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

33442000000

usd

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

85923000000

usd

CY2023Q2

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

3434000000

usd

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

7389000000

usd

CY2024Q2

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

420000000

usd

CY2023Q2

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

455000000

usd

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

843000000

usd

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

914000000

usd

CY2024Q2

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

58111000000

usd

CY2023Q2

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

46365000000

usd

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

113110000000

usd

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

90867000000

usd

CY2024Q2

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

usd

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

-19000000

usd

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

usd

CY2024Q2

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-48000000

usd

CY2023Q2

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

26000000

usd

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-1884000000

usd

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-30000000

usd

CY2024Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

1989000000

usd

CY2023Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

1884000000

usd

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

9.15

CY2024Q2

us-gaap

Profit Loss

ProfitLoss

1629000000

usd

CY2023Q2

us-gaap

Profit Loss

ProfitLoss

1510000000

usd

us-gaap

Profit Loss

ProfitLoss

1417000000

usd

us-gaap

Profit Loss

ProfitLoss

2816000000

usd

CY2024Q2

ci

Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax

108000000

usd

CY2023Q2

ci

Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax

20000000

usd

ci

Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax

229000000

usd

ci

Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax

214000000

usd

CY2024Q2

ci

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity

-5000000

usd

CY2023Q2

ci

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity

-19000000

usd

ci

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity

-31000000

usd

ci

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity

-3000000

usd

CY2024Q2

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

9000000

usd

CY2023Q2

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

-7000000

usd

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

4000000

usd

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

-17000000

usd

CY2024Q2

ci

Other Comprehensive Income Loss Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity

-118000000

usd

CY2023Q2

ci

Other Comprehensive Income Loss Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity

-109000000

usd

ci

Other Comprehensive Income Loss Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity

-578000000

usd

ci

Other Comprehensive Income Loss Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity

-220000000

usd

CY2024Q2

ci

Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity

ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity

1511000000

usd

CY2023Q2

ci

Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity

ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity

1401000000

usd

ci

Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity

ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity

839000000

usd

ci

Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity

ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity

2596000000

usd

CY2024Q2

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

0

usd

CY2023Q2

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

45000000

usd

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

0

usd

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

79000000

usd

CY2023Q2

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

5000000

usd

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

146000000

usd

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

10000000

usd

CY2024Q2

us-gaap

Assets

155446000000

usd

CY2023Q4

us-gaap

Assets

152761000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5616000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5514000000

usd

CY2024Q2

ci

Pharmacy And Service Costs Payable

PharmacyAndServiceCostsPayable

27503000000

usd

CY2024Q2

us-gaap

Debt Current

DebtCurrent

1717000000

usd

CY2024Q2

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2919000

shares

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

76000000

usd

ci

Transaction Related Costs

TransactionRelatedCosts

7000000

usd

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

6000000

usd

CY2023Q2

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

usd

CY2023Q2

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1460000000

usd

CY2024Q2

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

281133000

shares

CY2023Q2

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2367000

shares

CY2024Q2

us-gaap

Debt Current

DebtCurrent

1717000000

usd

CY2024Q2

us-gaap

Interest Expense Debt

InterestExpenseDebt

378000000

usd

us-gaap

Interest Expense Debt

InterestExpenseDebt

747000000

usd

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

Q2

dei

Entity Central Index Key

EntityCentralIndexKey

0001739940

CY2023Q4

ci

Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Sold That Remain Outstanding

AccountsReceivableUncommittedFactoringFacilityAccountsReceivableSoldThatRemainOutstanding

0

usd

CY2023Q4

us-gaap

Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration

SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration

http://fasb.org/us-gaap/2024#AccountsPayableCurrent

CY2024Q2

us-gaap

Supplier Finance Program Obligation Current Statement Of Financial Position Extensible Enumeration

SupplierFinanceProgramObligationCurrentStatementOfFinancialPositionExtensibleEnumeration

http://fasb.org/us-gaap/2024#AccountsPayableCurrent

us-gaap

Derivative Gain Loss On Derivative Net

DerivativeGainLossOnDerivativeNet

usd

CY2024Q1

us-gaap

Derivative Gain Loss On Derivative Net

DerivativeGainLossOnDerivativeNet

usd

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax

usd

CY2024Q1

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax

usd

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax

usd

CY2024Q1

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax

usd

CY2024Q2

ci

Impairments Requiring Certain Assets And Liabiliaties To Be Measured At Fair Value

ImpairmentsRequiringCertainAssetsAndLiabiliatiesToBeMeasuredAtFairValue

usd

ci

Impairments Requiring Certain Assets And Liabiliaties To Be Measured At Fair Value

ImpairmentsRequiringCertainAssetsAndLiabiliatiesToBeMeasuredAtFairValue

usd

CY2024Q2

us-gaap

Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount

usd

CY2023Q2

us-gaap

Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount

usd

us-gaap

Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount

usd

us-gaap

Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount

usd

CY2024Q2

us-gaap

Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount

usd

CY2023Q2

us-gaap

Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount

usd

us-gaap

Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount

usd

us-gaap

Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount

usd

dei

Document Period End Date

DocumentPeriodEndDate

2024-06-30

dei

Document Transition Report

DocumentTransitionReport

false

dei

Entity File Number

EntityFileNumber

001-38769

dei

Entity Registrant Name

EntityRegistrantName

The Cigna Group

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

6972000000

usd

CY2024Q2

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-375000000

usd

CY2023Q2

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-363000000

usd

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-697000000

usd

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-721000000

usd

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

2068000000

usd

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

3485000000

usd

CY2024Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

360000000

usd

CY2023Q2

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

374000000

usd

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

651000000

usd

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

669000000

usd

CY2024Q2

us-gaap

Profit Loss

ProfitLoss

1629000000

usd

CY2023Q2

us-gaap

Profit Loss

ProfitLoss

1510000000

usd

us-gaap

Profit Loss

ProfitLoss

1417000000

usd

us-gaap

Profit Loss

ProfitLoss

2816000000

usd

CY2024Q2

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

81000000

usd

CY2023Q2

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

50000000

usd

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

146000000

usd

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

89000000

usd

CY2024Q2

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1548000000

usd

CY2023Q2

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1460000000

usd

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1271000000

usd

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

2727000000

usd

CY2024Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

5.51

CY2023Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

4.96

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

4.48

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

9.24

CY2024Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

5.45

CY2023Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

4.92

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

4.43

CY2024Q2

ci

Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent

OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent

-212000000

usd

CY2023Q2

ci

Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent

OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent

-117000000

usd

ci

Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent

OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent

-772000000

usd

ci

Oci Liability For Future Policy Benefit And Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Reclassification Adjustment And Tax Portion Attributable To Parent

OCILiabilityForFuturePolicyBenefitAndMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterReclassificationAdjustmentAndTaxPortionAttributableToParent

-448000000

usd

CY2024Q2

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

81000000

usd

CY2024Q2

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

81000000

usd

CY2023Q2

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

1351000000

usd

CY2024Q2

us-gaap

Assets Of Disposal Group Including Discontinued Operation Current

AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

5411000000

usd

CY2023Q4

us-gaap

Assets Of Disposal Group Including Discontinued Operation Current

AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

3068000000

usd

CY2024Q2

us-gaap

Assets Current

AssetsCurrent

46215000000

usd

CY2023Q4

us-gaap

Assets Current

AssetsCurrent

37351000000

usd

CY2024Q2

us-gaap

Long Term Investments

LongTermInvestments

15944000000

usd

CY2023Q4

us-gaap

Long Term Investments

LongTermInvestments

17985000000

usd

CY2024Q2

ci

Reinsurance Recoverables Non Current

ReinsuranceRecoverablesNonCurrent

4595000000

usd

CY2023Q4

ci

Reinsurance Recoverables Non Current

ReinsuranceRecoverablesNonCurrent

4835000000

usd

CY2024Q2

us-gaap

Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization

PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

3551000000

usd

CY2023Q4

us-gaap

Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization

PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

3695000000

usd

CY2024Q2

us-gaap

Goodwill

44258000000

usd

CY2023Q4

us-gaap

Goodwill

44259000000

usd

CY2024Q2

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

30176000000

usd

CY2023Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

30863000000

usd

CY2024Q2

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

3276000000

usd

CY2023Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

3421000000

usd

CY2024Q2

us-gaap

Separate Account Assets

SeparateAccountAssets

7431000000

usd

CY2023Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

7430000000

usd

CY2024Q2

us-gaap

Disposal Group Including Discontinued Operation Assets Noncurrent

DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent

0

usd

CY2023Q4

us-gaap

Disposal Group Including Discontinued Operation Assets Noncurrent

DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent

2922000000

usd

CY2023Q4

ci

Pharmacy And Service Costs Payable

PharmacyAndServiceCostsPayable

19815000000

usd

CY2024Q2

us-gaap

Accounts Payable Current

AccountsPayableCurrent

9275000000

usd

CY2023Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

8553000000

usd

CY2024Q2

ci

Accrued Expenses And Other Liabilities

AccruedExpensesAndOtherLiabilities

9003000000

usd

CY2023Q4

ci

Accrued Expenses And Other Liabilities

AccruedExpensesAndOtherLiabilities

9955000000

usd

CY2023Q4

us-gaap

Debt Current

DebtCurrent

2775000000

usd

CY2024Q2

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Current

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

2259000000

usd

CY2023Q4

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Current

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

2104000000

usd

CY2024Q2

us-gaap

Liabilities Current

LiabilitiesCurrent

55373000000

usd

CY2023Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

48716000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

10449000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

10904000000

usd

CY2024Q2

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

6953000000

usd

CY2023Q4

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

7173000000

usd

CY2024Q2

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

3538000000

usd

CY2023Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

3441000000

usd

CY2024Q2

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

30175000000

usd

CY2023Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

28155000000

usd

CY2024Q2

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

7431000000

usd

CY2023Q4

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

7430000000

usd

CY2024Q2

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Noncurrent

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent

0

usd

CY2023Q4

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Noncurrent

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent

591000000

usd

CY2024Q2

us-gaap

Liabilities

113919000000

usd

CY2023Q4

us-gaap

Liabilities

106410000000

usd

CY2024Q2

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2023Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

usd

CY2024Q2

us-gaap

Redeemable Noncontrolling Interest Equity Carrying Amount

RedeemableNoncontrollingInterestEquityCarryingAmount

0

usd

CY2023Q4

us-gaap

Redeemable Noncontrolling Interest Equity Carrying Amount

RedeemableNoncontrollingInterestEquityCarryingAmount

107000000

usd

CY2024Q2

us-gaap

Common Stock Value

CommonStockValue

4000000

usd

CY2023Q4

us-gaap

Common Stock Value

CommonStockValue

4000000

usd

CY2024Q2

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

31048000000

usd

CY2023Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

30669000000

usd

CY2024Q2

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-2442000000

usd

CY2023Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-1864000000

usd

CY2024Q2

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

42132000000

usd

CY2023Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

41652000000

usd

CY2024Q2

us-gaap

Treasury Stock Value

TreasuryStockValue

29410000000

usd

CY2023Q4

us-gaap

Treasury Stock Value

TreasuryStockValue

24238000000

usd

CY2024Q2

us-gaap

Stockholders Equity

StockholdersEquity

41332000000

usd

CY2023Q4

us-gaap

Stockholders Equity

StockholdersEquity

46223000000

usd

CY2024Q2

us-gaap

Minority Interest

MinorityInterest

195000000

usd

CY2023Q4

us-gaap

Minority Interest

MinorityInterest

21000000

usd

CY2024Q2

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

41527000000

usd

CY2023Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

46244000000

usd

CY2024Q2

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

155446000000

usd

CY2023Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

152761000000

usd

CY2024Q2

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2023Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2024Q2

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

402000000

shares

CY2023Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

400000000

shares

CY2024Q2

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2023Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2024Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

41350000000

usd

CY2024Q1

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

0

usd

CY2024Q2

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

115000000

usd

CY2024Q2

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

-118000000

usd

CY2024Q2

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

0

usd

CY2024Q2

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

1629000000

usd

CY2024Q2

us-gaap

Temporary Equity Net Income

TemporaryEquityNetIncome

0

usd

CY2024Q2

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.40

CY2024Q2

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

394000000

usd

CY2024Q2

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

1000000000

usd

CY2024Q2

ci

Noncontrolling Interest Other Changes

NoncontrollingInterestOtherChanges

-55000000

usd

CY2024Q2

us-gaap

Temporary Equity Other Changes

TemporaryEquityOtherChanges

0

usd

CY2024Q2

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

41527000000

usd

CY2024Q2

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

0

usd

CY2023Q1

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

44518000000

usd

CY2023Q1

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

78000000

usd

CY2023Q2

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

105000000

usd

CY2023Q2

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

-109000000

usd

CY2023Q2

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

0

usd

CY2023Q2

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

1465000000

usd

CY2023Q2

us-gaap

Temporary Equity Net Income

TemporaryEquityNetIncome

45000000

usd

CY2023Q2

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.23

CY2023Q2

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

365000000

usd

CY2023Q2

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

146000000

usd

CY2023Q2

ci

Noncontrolling Interest Other Changes

NoncontrollingInterestOtherChanges

-4000000

usd

CY2023Q2

us-gaap

Temporary Equity Other Changes

TemporaryEquityOtherChanges

-61000000

usd

CY2023Q2

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

45464000000

usd

CY2023Q2

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

62000000

usd

CY2023Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

46244000000

usd

CY2023Q4

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

107000000

usd

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

264000000

usd

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

-578000000

usd

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

0

usd

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

1417000000

usd

us-gaap

Temporary Equity Net Income

TemporaryEquityNetIncome

0

usd

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

2.80

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

791000000

usd

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

5057000000

usd

ci

Noncontrolling Interest Other Changes

NoncontrollingInterestOtherChanges

28000000

usd

us-gaap

Temporary Equity Other Changes

TemporaryEquityOtherChanges

-107000000

usd

CY2024Q2

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

41527000000

usd

CY2024Q2

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

0

usd

CY2022Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

44688000000

usd

CY2022Q4

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

66000000

usd

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

100000000

usd

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

-220000000

usd

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

0

usd

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

2737000000

usd

us-gaap

Temporary Equity Net Income

TemporaryEquityNetIncome

79000000

usd

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

2.46

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

731000000

usd

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

1104000000

usd

ci

Noncontrolling Interest Other Changes

NoncontrollingInterestOtherChanges

-6000000

usd

us-gaap

Temporary Equity Other Changes

TemporaryEquityOtherChanges

-83000000

usd

CY2023Q2

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

45464000000

usd

CY2023Q2

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

62000000

usd

us-gaap

Profit Loss

ProfitLoss

1417000000

usd

us-gaap

Profit Loss

ProfitLoss

2816000000

usd

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

1479000000

usd

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

1504000000

usd

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-1884000000

usd

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-30000000

usd

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

199000000

usd

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

207000000

usd

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

-19000000

usd

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

usd

us-gaap

Increase Decrease In Accounts And Other Receivables

IncreaseDecreaseInAccountsAndOtherReceivables

7313000000

usd

us-gaap

Increase Decrease In Accounts And Other Receivables

IncreaseDecreaseInAccountsAndOtherReceivables

1144000000

usd

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-472000000

usd

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-263000000

usd

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

559000000

usd

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

-109000000

usd

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

-125000000

usd

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

1727000000

usd

ci

Increase Decrease In Pharmacy And Service Costs Payable

IncreaseDecreaseInPharmacyAndServiceCostsPayable

7820000000

usd

ci

Increase Decrease In Pharmacy And Service Costs Payable

IncreaseDecreaseInPharmacyAndServiceCostsPayable

1547000000

usd

ci

Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities

IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities

-15000000

usd

ci

Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities

IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities

638000000

usd

us-gaap

Increase Decrease In Other Operating Capital Net

IncreaseDecreaseInOtherOperatingCapitalNet

-225000000

usd

us-gaap

Increase Decrease In Other Operating Capital Net

IncreaseDecreaseInOtherOperatingCapitalNet

-237000000

usd

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

5105000000

usd

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

7520000000

usd

ci

Proceeds From Sale Of Debt And Equity Securities

ProceedsFromSaleOfDebtAndEquitySecurities

393000000

usd

ci

Proceeds From Sale Of Debt And Equity Securities

ProceedsFromSaleOfDebtAndEquitySecurities

646000000

usd

ci

Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities

414000000

usd

ci

Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities

502000000

usd

us-gaap

Proceeds From Collection Of Loans Receivable

ProceedsFromCollectionOfLoansReceivable

37000000

usd

us-gaap

Proceeds From Collection Of Loans Receivable

ProceedsFromCollectionOfLoansReceivable

82000000

usd

us-gaap

Proceeds From Sale And Maturity Of Other Investments

ProceedsFromSaleAndMaturityOfOtherInvestments

451000000

usd

us-gaap

Proceeds From Sale And Maturity Of Other Investments

ProceedsFromSaleAndMaturityOfOtherInvestments

313000000

usd

ci

Payments To Acquire Debt And Equity Securities

PaymentsToAcquireDebtAndEquitySecurities

493000000

usd

ci

Payments To Acquire Debt And Equity Securities

PaymentsToAcquireDebtAndEquitySecurities

3339000000

usd

us-gaap

Payments To Acquire Mortgage Notes Receivable

PaymentsToAcquireMortgageNotesReceivable

52000000

usd

us-gaap

Payments To Acquire Mortgage Notes Receivable

PaymentsToAcquireMortgageNotesReceivable

59000000

usd

us-gaap

Payments To Acquire Other Investments

PaymentsToAcquireOtherInvestments

865000000

usd

us-gaap

Payments To Acquire Other Investments

PaymentsToAcquireOtherInvestments

685000000

usd

ci

Payments For Proceeds From Property Plant And Equipment

PaymentsForProceedsFromPropertyPlantAndEquipment

670000000

usd

ci

Payments For Proceeds From Property Plant And Equipment

PaymentsForProceedsFromPropertyPlantAndEquipment

805000000

usd

us-gaap

Proceeds From Divestiture Of Businesses Net Of Cash Divested

ProceedsFromDivestitureOfBusinessesNetOfCashDivested

0

usd

us-gaap

Proceeds From Divestiture Of Businesses Net Of Cash Divested

ProceedsFromDivestitureOfBusinessesNetOfCashDivested

27000000

usd

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

350000000

usd

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

79000000

usd

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-1135000000

usd

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-3397000000

usd

us-gaap

Additions To Contract Holders Funds

AdditionsToContractHoldersFunds

84000000

usd

us-gaap

Additions To Contract Holders Funds

AdditionsToContractHoldersFunds

96000000

usd

us-gaap

Withdrawal From Contract Holders Funds

WithdrawalFromContractHoldersFunds

135000000

usd

us-gaap

Withdrawal From Contract Holders Funds

WithdrawalFromContractHoldersFunds

100000000

usd

ci

Proceeds From Repayments Of Other Short Term Debt

ProceedsFromRepaymentsOfOtherShortTermDebt

-467000000

usd

ci

Proceeds From Repayments Of Other Short Term Debt

ProceedsFromRepaymentsOfOtherShortTermDebt

183000000

usd

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

3000000000

usd

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

80000000

usd

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

4462000000

usd

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

1491000000

usd

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

5012000000

usd

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

1116000000

usd

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

221000000

usd

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

59000000

usd

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

793000000

usd

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

730000000

usd

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

-198000000

usd

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

-275000000

usd

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-4838000000

usd

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-472000000

usd

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

-12000000

usd

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

9000000

usd

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-880000000

usd

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

3660000000

usd

CY2023Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

8337000000

usd

CY2022Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

5976000000

usd

CY2024Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

7457000000

usd

CY2023Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

9636000000

usd

CY2024Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations

625000000

usd

CY2023Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations

0

usd

CY2024Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

6832000000

usd

CY2023Q2

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

9636000000

usd

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

567000000

usd

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

926000000

usd

us-gaap

Interest Paid Net

InterestPaidNet

643000000

usd

us-gaap

Interest Paid Net

InterestPaidNet

632000000

usd

us-gaap

Nature Of Operations

NatureOfOperations

<div style="margin-bottom:10pt">Note 1 – Description of Business</div><div>The Cigna Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future for every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. Powered by our people and our brands, we advance our mission to improve the health and vitality of those we serve. </div><div> </div><div>Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services. The majority of these products and services are offered through employers and other entities such as governmental and non-governmental organizations, unions and associations. Cigna Healthcare also offers health and dental insurance and Medicare products to individuals in the United States and select international markets. In addition to these operations, The Cigna Group also has certain run-off operations.</div><div> </div><div style="margin-bottom:10pt">A full description of our segments follows:</div><div>The Evernorth Health Services reportable segment includes the Pharmacy Benefit Services and the Specialty and Care Services operating segments, which partner with health plans, employers, governmental organizations and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions.</div><div> </div><div>Pharmacy Benefit Services drives high-quality, cost-effective pharmacy care through various services such as drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management and access to our home delivery pharmacy. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help our clients drive better whole-person health outcomes through Care Delivery and Management Solutions. The Company's reporting units remain aligned with its operating segments and Evernorth Health Services' goodwill was allocated on a relative fair value basis.</div><div> </div><div style="margin-bottom:10pt">The Cigna Healthcare reportable segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. U.S. Healthcare provides medical plans and specialty benefits and solutions for insured and self-insured clients, Medicare Advantage, Medicare Supplement and Medicare Stand-Alone Prescription Drug Plans for seniors and individual health insurance plans. International Health provides health care solutions in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. </div><div style="margin-bottom:10pt">In January 2024, the Company entered into a definitive agreement to sell the Medicare Advantage, Medicare Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits and CareAllies businesses within the U.S. Healthcare operating segment to Health Care Service Corporation ("HCSC") for approximately $3.3 billion cash, subject to applicable regulatory approvals and other customary closing conditions (the "HCSC transaction"). See Note 5 to the Consolidated Financial Statements for further information.</div><div style="margin-bottom:10pt">Other Operations comprises the remainder of our business operations, which includes our continuing business (corporate-owned life insurance ("COLI")) and our run-off and other non-strategic businesses. Our run-off businesses include (i) variable annuity reinsurance business that was effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013, (ii) settlement annuity business, and (iii) individual life insurance and annuity and retirement benefits businesses which were sold through reinsurance agreements.</div><div style="margin-bottom:10pt">Corporate reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate financing less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs and eliminations for products and services sold between segments.</div>

CY2024Q2

ci

Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale

PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale

12555000000

usd

CY2023Q4

ci

Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale

PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale

8169000000

usd

CY2024Q2

ci

Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale

NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale

10946000000

usd

CY2023Q4

ci

Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale

NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale

8044000000

usd

CY2024Q2

ci

Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale

InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale

2325000000

usd

CY2023Q4

ci

Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale

InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale

2359000000

usd

CY2024Q2

ci

Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale

AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale

289000000

usd

CY2023Q4

ci

Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale

AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale

272000000

usd

CY2024Q2

ci

Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale

ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale

26115000000

usd

CY2023Q4

ci

Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale

ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale

18844000000

usd

CY2024Q2

us-gaap

Receivables Net Current

ReceivablesNetCurrent

25111000000

usd

CY2023Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

17722000000

usd

CY2024Q2

ci

Allowance For Receivables Current

AllowanceForReceivablesCurrent

4400000000

usd

CY2023Q4

ci

Allowance For Receivables Current

AllowanceForReceivablesCurrent

3700000000

usd

CY2024Q2

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

95000000

usd

CY2023Q4

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

90000000

usd

CY2023Q3

ci

Accounts Receivable Uncommitted Factoring Facility Initial Term

AccountsReceivableUncommittedFactoringFacilityInitialTerm

P2Y

CY2023Q3

ci

Accounts Receivable Uncommitted Factoring Facility Automatic Renewal Term

AccountsReceivableUncommittedFactoringFacilityAutomaticRenewalTerm

P1Y

CY2023Q3

ci

Accounts Receivable Uncommitted Factoring Facility Total Capacity

AccountsReceivableUncommittedFactoringFacilityTotalCapacity

1000000000.0

usd

CY2024Q2

ci

Accounts Receivable Uncommitted Factoring Facility Total Capacity

AccountsReceivableUncommittedFactoringFacilityTotalCapacity

1500000000

usd

CY2024Q2

ci

Accounts Receivable Uncommitted Factoring Facility Amount Sold

AccountsReceivableUncommittedFactoringFacilityAmountSold

1300000000

usd

ci

Accounts Receivable Uncommitted Factoring Facility Amount Sold

AccountsReceivableUncommittedFactoringFacilityAmountSold

3200000000

usd

CY2024Q2

ci

Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Sold That Remain Outstanding

AccountsReceivableUncommittedFactoringFacilityAccountsReceivableSoldThatRemainOutstanding

322000000

usd

CY2024Q2

ci

Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted

AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted

713000000

usd

CY2023Q4

ci

Accounts Receivable Uncommitted Factoring Facility Accounts Receivable Received But Not Remitted

AccountsReceivableUncommittedFactoringFacilityAccountsReceivableReceivedButNotRemitted

515000000

usd

CY2024Q2

us-gaap

Supplier Finance Program Obligation Current

SupplierFinanceProgramObligationCurrent

1700000000

usd

CY2023Q4

us-gaap

Supplier Finance Program Obligation Current

SupplierFinanceProgramObligationCurrent

1500000000

usd

CY2024Q2

ci

Supplier Finance Program Outstanding Payment Obligation Current Voluntarily Elected To Be Sold

SupplierFinanceProgramOutstandingPaymentObligationCurrentVoluntarilyElectedToBeSold

348000000

usd

CY2024Q2

ci

Transaction Related Costs

TransactionRelatedCosts

63000000

usd

CY2024Q2

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

47000000

usd

ci

Transaction Related Costs

TransactionRelatedCosts

100000000

usd

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

76000000

usd

CY2023Q2

ci

Transaction Related Costs

TransactionRelatedCosts

6000000

usd

CY2023Q2

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

5000000

usd

ci

Transaction Related Costs

TransactionRelatedCosts

7000000

usd

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

6000000

usd

CY2024Q2

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1548000000

usd

CY2024Q2

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1548000000

usd

CY2023Q2

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1460000000

usd

CY2024Q2

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

281133000

shares

CY2024Q2

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

281133000

shares

CY2023Q2

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

294512000

shares

CY2023Q2

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

294512000

shares

CY2024Q2

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2919000

shares

CY2023Q2

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2367000

shares

CY2023Q2

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2367000

shares

CY2024Q2

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2919000

shares

CY2024Q2

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

284052000

shares

CY2023Q2

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

294512000

shares

CY2023Q2

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

296879000

shares

CY2024Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

5.51

CY2024Q2

ci

Earnings Per Share Effect Of Dilution

EarningsPerShareEffectOfDilution

-0.06

CY2024Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

5.45

CY2023Q2

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

4.96

CY2023Q2

ci

Earnings Per Share Effect Of Dilution

EarningsPerShareEffectOfDilution

-0.04

CY2023Q2

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

4.92

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1271000000

usd

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

1271000000

usd

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

2727000000

usd

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

2727000000

usd

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

283799000

shares

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

283799000

shares

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

295105000

shares

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

295105000

shares

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3085000

shares

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3085000

shares

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2831000

shares

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2831000

shares

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

283799000

shares

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3085000

shares

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

286884000

shares

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

295105000

shares

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

2831000

shares

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

297936000

shares

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

4.48

ci

Earnings Per Share Effect Of Dilution

EarningsPerShareEffectOfDilution

-0.05

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

4.43

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

9.24

ci

Earnings Per Share Effect Of Dilution

EarningsPerShareEffectOfDilution

-0.09

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

9.15

CY2024Q2

us-gaap

Treasury Stock Common Shares

TreasuryStockCommonShares

122500000

shares

CY2023Q4

us-gaap

Treasury Stock Common Shares

TreasuryStockCommonShares

107400000

shares

CY2023Q2

us-gaap

Treasury Stock Common Shares

TreasuryStockCommonShares

103300000

shares

CY2024Q2

us-gaap

Commercial Paper

CommercialPaper

790000000

usd

CY2023Q4

us-gaap

Commercial Paper

CommercialPaper

1237000000

usd

CY2024Q2

ci

Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current

OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent

42000000

usd

CY2023Q4

ci

Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current

OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent

42000000

usd

CY2023Q4

us-gaap

Debt Current

DebtCurrent

2775000000

usd

CY2024Q2

us-gaap

Other Long Term Debt Noncurrent

OtherLongTermDebtNoncurrent

52000000

usd

CY2023Q4

us-gaap

Other Long Term Debt Noncurrent

OtherLongTermDebtNoncurrent

66000000

usd

CY2024Q2

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

30175000000

usd

CY2023Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

28155000000

usd

srt

Commercial Paper Average Rate Paid

CommercialPaperAverageRatePaid

0.0547

CY2024Q1

us-gaap

Debt Instrument Repurchased Face Amount

DebtInstrumentRepurchasedFaceAmount

1800000000

usd

CY2023Q2

us-gaap

Interest Expense Debt

InterestExpenseDebt

350000000

usd

us-gaap

Interest Expense Debt

InterestExpenseDebt

695000000

usd

CY2024Q1

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.40

CY2024Q1

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

401000000

usd

CY2024Q2

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.40

CY2024Q2

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

392000000

usd

CY2023Q1

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.23

CY2023Q1

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

368000000

usd

CY2023Q2

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.23

CY2023Q2

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

362000000

usd

us-gaap

Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense

ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense

<div>The Company's insurance and contractholder liabilities were comprised of the following:</div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom">June 30, 2024</td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom">December 31, 2023</td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">June 30, 2023</td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">(In millions)</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Non-current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Non-current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Unpaid claims and claim expenses</td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt">Cigna Healthcare</div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">5,124 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">78 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">5,202 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">5,017 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">75 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">5,092 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">5,336 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom">Other Operations</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">165 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">151 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">316 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">99 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">154 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">253 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">297 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Future policy benefits</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt">Cigna Healthcare</div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">90 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">506 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">596 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">97 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">518 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">615 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">595 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom">Other Operations</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">162 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,200 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,362 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">163 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,375 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,538 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,587 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom">Contractholder deposit funds</td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt">Cigna Healthcare</div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">10 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">125 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">135 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">12 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">133 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">145 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">158 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom">Other Operations</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">360 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">6,021 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">6,381 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">362 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">6,178 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">6,540 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">6,647 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Market risk benefits</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">25 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">840 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">865 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">37 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">966 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">1,003 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">1,069 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom">Unearned premiums</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">737 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">28 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">765 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">846 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">22 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">868 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">1,425 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Total</td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">6,673 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">10,949 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">17,622 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">6,633 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">11,421 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">18,054 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div>Insurance and contractholder liabilities classified as liabilities of businesses held for sale (1)</div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(1,057)</td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(500)</td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(1,557)</td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(1,119)</td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(517)</td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(1,636)</td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Total insurance and contractholder liabilities</td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,616 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">10,449 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">16,065 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,514 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">10,904 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">16,418 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">19,114 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt">(1) Amounts classified as liabilities of businesses held for sale include $900 million of Unpaid claims, $417 million of Future policy benefits, $129 million of Unearned premiums and $111 million of Contractholder deposit funds as of June 30, 2024 and $823 million of Unpaid claims, $429 million of Future policy benefits, $261 million of Unearned premiums and $123 million of Contractholder deposit funds as of December 31, 2023.</div><div style="margin-bottom:10pt">Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment was as follows:</div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.733%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.707%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom">Six Months Ended June 30,</td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">(In millions)</td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center">2024 (1)</div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">2023</td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Beginning balance</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,092 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">4,176 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Less: Reinsurance and other amounts recoverable</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">236 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">221 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Beginning balance, net</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,856 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,955 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Incurred costs related to:</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Current year</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">18,821 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">17,974 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(284)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(202)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Total incurred</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">18,537 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">17,772 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Paid costs related to:</td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Current year</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">14,397 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">13,408 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,960 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,199 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Total paid</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">18,357 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">16,607 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Ending balance, net</td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">5,036 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">5,120 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom">Add: Reinsurance and other amounts recoverable</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">166 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">216 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Ending balance</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">5,202 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">5,336 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div>(1) Includes unpaid claims amounts classified as liabilities of businesses held for sale. As of June 30, 2024 and December 31, 2023, $900 million and $823 million classified as liabilities of businesses held for sale, respectively.</div>

CY2024Q2

ci

Market Risk Benefit Liability Amount Current

MarketRiskBenefitLiabilityAmountCurrent

25000000

usd

CY2024Q2

ci

Market Risk Benefit Liability Amount Noncurrent

MarketRiskBenefitLiabilityAmountNoncurrent

840000000

usd

CY2024Q2

us-gaap

Market Risk Benefit Liability Amount

MarketRiskBenefitLiabilityAmount

865000000

usd

CY2023Q4

ci

Market Risk Benefit Liability Amount Current

MarketRiskBenefitLiabilityAmountCurrent

37000000

usd

CY2023Q4

ci

Market Risk Benefit Liability Amount Noncurrent

MarketRiskBenefitLiabilityAmountNoncurrent

966000000

usd

CY2023Q4

us-gaap

Market Risk Benefit Liability Amount

MarketRiskBenefitLiabilityAmount

1003000000

usd

CY2023Q2

us-gaap

Market Risk Benefit Liability Amount

MarketRiskBenefitLiabilityAmount

1069000000

usd

CY2024Q2

ci

Unearned Premiums Current Including Disposal Groups

UnearnedPremiumsCurrentIncludingDisposalGroups

737000000

usd

CY2024Q2

ci

Unearned Premiums Noncurrent Including Disposal Groups

UnearnedPremiumsNoncurrentIncludingDisposalGroups

28000000

usd

CY2024Q2

ci

Unearned Premiums Including Disposal Groups

UnearnedPremiumsIncludingDisposalGroups

765000000

usd

CY2023Q4

ci

Unearned Premiums Current Including Disposal Groups

UnearnedPremiumsCurrentIncludingDisposalGroups

846000000

usd

CY2023Q4

ci

Unearned Premiums Noncurrent Including Disposal Groups

UnearnedPremiumsNoncurrentIncludingDisposalGroups

22000000

usd

CY2023Q4

ci

Unearned Premiums Including Disposal Groups

UnearnedPremiumsIncludingDisposalGroups

868000000

usd

CY2023Q2

us-gaap

Unearned Premiums

UnearnedPremiums

1425000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities Current Including Disposal Groups

InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups

6673000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities Noncurrent Including Disposal Groups

InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups

10949000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities Including Disposal Groups

InsuranceAndContractholderLiabilitiesIncludingDisposalGroups

17622000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities Current Including Disposal Groups

InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups

6633000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities Noncurrent Including Disposal Groups

InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups

11421000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities Including Disposal Groups

InsuranceAndContractholderLiabilitiesIncludingDisposalGroups

18054000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5616000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

10449000000

usd

CY2024Q2

ci

Insurance And Contractholder Liabilities

InsuranceAndContractholderLiabilities

16065000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5514000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

10904000000

usd

CY2023Q4

ci

Insurance And Contractholder Liabilities

InsuranceAndContractholderLiabilities

16418000000

usd

CY2023Q2

ci

Insurance And Contractholder Liabilities

InsuranceAndContractholderLiabilities

19114000000

usd

CY2024Q2

ci

Policyholder Contract Balance Percent Reinsured Externally

PolicyholderContractBalancePercentReinsuredExternally

0.38

ci

Annuitization Election Period

AnnuitizationElectionPeriod

P30D

CY2023Q4

us-gaap

Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk

MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk

1003000000

usd

CY2022Q4

us-gaap

Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk

MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk

1268000000

usd

CY2023Q4

us-gaap

Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change

MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange

1085000000

usd

CY2022Q4

us-gaap

Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change

MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange

1379000000

usd

ci

Market Risk Benefit Increase Decrease Due To Expected Run Off

MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff

-6000000

usd

ci

Market Risk Benefit Increase Decrease Due To Expected Run Off

MarketRiskBenefitIncreaseDecreaseDueToExpectedRunOff

-14000000

usd

ci

Market Risk Benefit Increase Decrease From Interest Rate Change And Equity Market Change

MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange

-133000000

usd

ci

Market Risk Benefit Increase Decrease From Interest Rate Change And Equity Market Change

MarketRiskBenefitIncreaseDecreaseFromInterestRateChangeAndEquityMarketChange

-194000000

usd

us-gaap

Market Risk Benefit Increase Decrease From Actual Policyholder Behavior Different From Expected

MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected

-17000000

usd

us-gaap

Market Risk Benefit Increase Decrease From Actual Policyholder Behavior Different From Expected

MarketRiskBenefitIncreaseDecreaseFromActualPolicyholderBehaviorDifferentFromExpected

8000000

usd

us-gaap

Market Risk Benefit Increase Decrease From Other Assumption

MarketRiskBenefitIncreaseDecreaseFromOtherAssumption

0

usd

us-gaap

Market Risk Benefit Increase Decrease From Other Assumption

MarketRiskBenefitIncreaseDecreaseFromOtherAssumption

-32000000

usd

CY2024Q2

us-gaap

Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change

MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange

929000000

usd

CY2023Q2

us-gaap

Market Risk Benefit Before Reinsurance And Cumulative Increase Decrease From Instrument Specific Credit Risk Change

MarketRiskBenefitBeforeReinsuranceAndCumulativeIncreaseDecreaseFromInstrumentSpecificCreditRiskChange

1147000000

usd

CY2024Q2

us-gaap

Aoci Market Risk Benefit Instrument Specific Credit Risk Before Tax

AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax

64000000

usd

CY2023Q2

us-gaap

Aoci Market Risk Benefit Instrument Specific Credit Risk Before Tax

AociMarketRiskBenefitInstrumentSpecificCreditRiskBeforeTax

78000000

usd

CY2024Q2

us-gaap

Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk

MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk

865000000

usd

CY2023Q2

us-gaap

Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk

MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk

1069000000

usd

CY2024Q2

us-gaap

Market Risk Benefit Reinsurance Recoverable After Allowance

MarketRiskBenefitReinsuranceRecoverableAfterAllowance

927000000

usd

CY2023Q2

us-gaap

Market Risk Benefit Reinsurance Recoverable After Allowance

MarketRiskBenefitReinsuranceRecoverableAfterAllowance

1143000000

usd

CY2024Q2

ci

Reinsurance Recoverables Gross Before Reclassification To Disposal Group Assets Held For Sale

ReinsuranceRecoverablesGrossBeforeReclassificationToDisposalGroupAssetsHeldForSale

4087000000

usd

CY2024Q2

ci

Reinsurance Recoverable Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale

ReinsuranceRecoverableAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

34000000

usd

CY2024Q2

ci

Reinsurance Recoverables Including Reinsurance Premium Paid Before Reclassification To Disposal Group Assets Held For Sale

ReinsuranceRecoverablesIncludingReinsurancePremiumPaidBeforeReclassificationToDisposalGroupAssetsHeldForSale

4980000000

usd

CY2024Q2

ci

Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale

ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

1162000000

usd

CY2024Q2

ci

Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale

LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

17251000000

usd

CY2024Q2

ci

Investments Before Reclassification To Disposal Group Assets Held For Sale

InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

18413000000

usd

CY2023Q4

ci

Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale

ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

1009000000

usd

CY2023Q4

ci

Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale

LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

19339000000

usd

CY2023Q4

ci

Investments Before Reclassification To Disposal Group Assets Held For Sale

InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

20348000000

usd

CY2024Q2

us-gaap

Short Term Investments

ShortTermInvestments

1068000000

usd

CY2024Q2

us-gaap

Long Term Investments

LongTermInvestments

15944000000

usd

CY2024Q2

us-gaap

Investments

17012000000

usd

CY2023Q4

us-gaap

Short Term Investments

ShortTermInvestments

925000000

usd

CY2023Q4

us-gaap

Long Term Investments

LongTermInvestments

17985000000

usd

CY2023Q4

us-gaap

Investments

18910000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date Year One Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateYearOneBeforeReclassificationToDisposalGroupAssetsHeldForSale

666000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year One Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearOneBeforeReclassificationToDisposalGroupAssetsHeldForSale

643000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Five Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFiveBeforeReclassificationToDisposalGroupAssetsHeldForSale

3732000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Five Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFiveBeforeReclassificationToDisposalGroupAssetsHeldForSale

3497000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year5 Through10 Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear5Through10BeforeReclassificationToDisposalGroupAssetsHeldForSale

3175000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year5 Through10 Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear5Through10BeforeReclassificationToDisposalGroupAssetsHeldForSale

2945000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year10 Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYear10BeforeReclassificationToDisposalGroupAssetsHeldForSale

2137000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year10 Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYear10BeforeReclassificationToDisposalGroupAssetsHeldForSale

1913000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Maturity Without Single Maturity Date Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleMaturityWithoutSingleMaturityDateAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

387000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Maturity Without Single Maturity Date Fair Value Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleMaturityWithoutSingleMaturityDateFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale

352000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

10097000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale

9350000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

10097000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

90000000

usd

CY2024Q2

ci

Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale

124000000

usd

CY2024Q2

ci

Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale

781000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale

9350000000

usd

CY2023Q4

ci

Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

10379000000

usd

CY2023Q4

ci

Debt Securities Available For Sale Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

33000000

usd

CY2023Q4

ci

Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale

195000000

usd

CY2023Q4

ci

Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale

686000000

usd

CY2023Q4

ci

Debt Securities Available For Sale Excluding Accrued Interest Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleExcludingAccruedInterestBeforeReclassificationToDisposalGroupAssetsHeldForSale

9855000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Unrealized Loss Position Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale

6712000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Unrealized Loss Position Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

7493000000

usd

CY2024Q2

ci

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

781000000

usd

CY2024Q2

ci

Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale

2491

position

CY2023Q4

ci

Debt Securities Available For Sale Unrealized Loss Position Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale

6633000000

usd

CY2023Q4

ci

Debt Securities Available For Sale Unrealized Loss Position Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

7319000000

usd

CY2023Q4

ci

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

686000000

usd

CY2023Q4

ci

Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale

2353

position

CY2024Q2

us-gaap

Equity Securities Fv Ni Cost

EquitySecuritiesFvNiCost

655000000

usd

CY2024Q2

us-gaap

Equity Securities Fv Ni Current And Noncurrent

EquitySecuritiesFvNiCurrentAndNoncurrent

46000000

usd

CY2023Q4

us-gaap

Equity Securities Fv Ni Cost

EquitySecuritiesFvNiCost

656000000

usd

CY2023Q4

us-gaap

Equity Securities Fv Ni Current And Noncurrent

EquitySecuritiesFvNiCurrentAndNoncurrent

51000000

usd

CY2024Q2

ci

Equity Securities Without Readily Determinable Fair Value Amortized Cost

EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost

3313000000

usd

CY2024Q2

us-gaap

Equity Securities Without Readily Determinable Fair Value Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

1562000000

usd

CY2023Q4

ci

Equity Securities Without Readily Determinable Fair Value Amortized Cost

EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost

3248000000

usd

CY2023Q4

us-gaap

Equity Securities Without Readily Determinable Fair Value Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

3311000000

usd

CY2024Q2

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost

3968000000

usd

CY2024Q2

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount

1608000000

usd

CY2023Q4

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost

3904000000

usd

CY2023Q4

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount

3362000000

usd

CY2024Q2

ci

Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale

OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

4446000000

usd

CY2023Q4

ci

Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale

OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

4181000000

usd

CY2024Q2

ci

Realized Investment Gain Loss Excluding Impairments

RealizedInvestmentGainLossExcludingImpairments

13000000

usd

CY2023Q2

ci

Realized Investment Gain Loss Excluding Impairments

RealizedInvestmentGainLossExcludingImpairments

31000000

usd

ci

Realized Investment Gain Loss Excluding Impairments

RealizedInvestmentGainLossExcludingImpairments

7000000

usd

ci

Realized Investment Gain Loss Excluding Impairments

RealizedInvestmentGainLossExcludingImpairments

-20000000

usd

CY2024Q2

ci

Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total

DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal

61000000

usd

CY2023Q2

ci

Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total

DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal

5000000

usd

ci

Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total

DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal

1891000000

usd

ci

Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Recovery And Impairments On Investments Total

DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseRecoveryAndImpairmentsOnInvestmentsTotal

10000000

usd

CY2024Q2

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-48000000

usd

CY2023Q2

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

26000000

usd

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-1884000000

usd

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

-30000000

usd

CY2024Q2

ci

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss

-2000000

usd

CY2023Q2

ci

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss

-6000000

usd

ci

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss

-6000000

usd

ci

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss

-5000000

usd

CY2024Q2

ci

Guaranteed Separate Account Assets

GuaranteedSeparateAccountAssets

572000000

usd

CY2023Q4

ci

Guaranteed Separate Account Assets

GuaranteedSeparateAccountAssets

578000000

usd

CY2024Q2

ci

Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy

NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy

6201000000

usd

CY2023Q4

ci

Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy

NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy

6172000000

usd

CY2024Q2

ci

Separate Account Assets Classified In Fair Value Hierarchy

SeparateAccountAssetsClassifiedInFairValueHierarchy

6773000000

usd

CY2023Q4

ci

Separate Account Assets Classified In Fair Value Hierarchy

SeparateAccountAssetsClassifiedInFairValueHierarchy

6750000000

usd

CY2024Q2

ci

Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient

NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient

658000000

usd

CY2023Q4

ci

Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient

NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient

680000000

usd

CY2024Q2

us-gaap

Separate Account Assets

SeparateAccountAssets

7431000000

usd

CY2023Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

7430000000

usd

CY2024Q2

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.181

CY2023Q2

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.199

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.315

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.192

CY2024Q2

ci

Deferred Tax Assets Investments Subject To Federal Capital Loss Utilization Rules

DeferredTaxAssetsInvestmentsSubjectToFederalCapitalLossUtilizationRules

689000000

usd

CY2024Q2

ci

Deferred Tax Assets Valuation Allowance Investments Subject To Federal Capital Loss Utilization Rules

DeferredTaxAssetsValuationAllowanceInvestmentsSubjectToFederalCapitalLossUtilizationRules

422000000

usd

us-gaap

Guarantees Indemnifications And Warranties Policies

GuaranteesIndemnificationsAndWarrantiesPolicies

Financial Guarantees: Retiree and Life Insurance BenefitsThe Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments.An additional liability is established if management believes that the Company will be required to make payments under the guarantees;Separate account assets supporting these guarantees are classified in Levels 1 and 2 of the GAAP fair value hierarchy.Certain Other GuaranteesThe Company had indemnification obligations as of June 30, 2024 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with laws or regulations or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a stated dollar amount or a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation.Guaranty Fund Assessments<div style="margin-bottom:10pt">The Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.</div>

CY2024Q2

ci

Transaction Related Costs

TransactionRelatedCosts

63000000

usd

CY2024Q2

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

47000000

usd

CY2023Q2

ci

Transaction Related Costs

TransactionRelatedCosts

6000000

usd

CY2023Q2

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

5000000

usd

ci

Transaction Related Costs

TransactionRelatedCosts

100000000

usd

CY2024Q2

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

0

usd

CY2024Q2

ci

Special Item Gain Loss On Sale Of Business Net Of Tax

SpecialItemGainLossOnSaleOfBusinessNetOfTax

0

usd

CY2023Q2

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

0

usd

CY2023Q2

ci

Special Item Gain Loss On Sale Of Business Net Of Tax

SpecialItemGainLossOnSaleOfBusinessNetOfTax

0

usd

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

-19000000

usd

ci

Special Item Gain Loss On Sale Of Business Net Of Tax

SpecialItemGainLossOnSaleOfBusinessNetOfTax

43000000

usd

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

0

usd

ci

Special Item Gain Loss On Sale Of Business Net Of Tax

SpecialItemGainLossOnSaleOfBusinessNetOfTax

0

usd

CY2024Q2

ci

Special Item Charge Benefit Tax Matters

SpecialItemChargeBenefitTaxMatters

0

usd

CY2024Q2

ci

Special Item Charge Benefit Tax Matters After Tax

SpecialItemChargeBenefitTaxMattersAfterTax

17000000

usd

CY2023Q2

ci

Special Item Charge Benefit Tax Matters

SpecialItemChargeBenefitTaxMatters

0

usd

CY2023Q2

ci

Special Item Charge Benefit Tax Matters After Tax

SpecialItemChargeBenefitTaxMattersAfterTax

0

usd

ci

Special Item Charge Benefit Tax Matters

SpecialItemChargeBenefitTaxMatters

0

usd

ci

Special Item Charge Benefit Tax Matters After Tax

SpecialItemChargeBenefitTaxMattersAfterTax

34000000

usd

ci

Special Item Charge Benefit Tax Matters

SpecialItemChargeBenefitTaxMatters

0

usd

ci

Special Item Charge Benefit Tax Matters After Tax

SpecialItemChargeBenefitTaxMattersAfterTax

0

usd

CY2024Q2

ci

Special Item Gain Or Loss Before Tax Attributable To Reporting Entity

SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity

-63000000

usd

CY2024Q2

ci

Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity

SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity

-64000000

usd

CY2023Q2

ci

Special Item Gain Or Loss Before Tax Attributable To Reporting Entity

SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity

-6000000

usd

CY2023Q2

ci

Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity

SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity

-5000000

usd

ci

Special Item Gain Or Loss Before Tax Attributable To Reporting Entity

SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity

-119000000

usd

ci

Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity

SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity

-67000000

usd

ci

Special Item Gain Or Loss Before Tax Attributable To Reporting Entity

SpecialItemGainOrLossBeforeTaxAttributableToReportingEntity

-7000000

usd

ci

Special Item Gain Or Loss Net Of Tax Attributable To Reporting Entity

SpecialItemGainOrLossNetOfTaxAttributableToReportingEntity

-6000000

usd

CY2024Q2

ci

Non Investment Revenue

NonInvestmentRevenue

60202000000

usd

CY2024Q2

us-gaap

Net Investment Income

NetInvestmentIncome

321000000

usd

CY2024Q2

us-gaap

Revenues

60523000000

usd

CY2024Q2

ci

Realized Investment Gains Losses Equity Method Investments

RealizedInvestmentGainsLossesEquityMethodInvestments

53000000

usd

CY2024Q2

ci

Segment Revenues

SegmentRevenues

60470000000

usd

CY2024Q2

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

1989000000

usd

CY2024Q2

ci

Income Loss Attributable To Noncontrolling Interest Before Tax

IncomeLossAttributableToNoncontrollingInterestBeforeTax

95000000

usd

CY2024Q2

ci

Realized Investment Gain Loss Including Equity Method Subsidiaries

RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries

5000000

usd

CY2024Q2

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

420000000

usd

CY2024Q2

ci

Transaction Related Costs

TransactionRelatedCosts

63000000

usd

CY2024Q2

ci

Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

2372000000

usd

CY2023Q2

ci

Transaction Related Costs

TransactionRelatedCosts

6000000

usd

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

-19000000

usd

ci

Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

4681000000

usd

ci

Non Investment Revenue

NonInvestmentRevenue

94548000000

usd

us-gaap

Net Investment Income

NetInvestmentIncome

555000000

usd

us-gaap

Revenues

95103000000

usd

ci

Realized Investment Gains Losses Equity Method Investments

RealizedInvestmentGainsLossesEquityMethodInvestments

8000000

usd

ci

Segment Revenues

SegmentRevenues

95095000000

usd

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

3485000000

usd

ci

Income Loss Attributable To Noncontrolling Interest Before Tax

IncomeLossAttributableToNoncontrollingInterestBeforeTax

98000000

usd

ci

Realized Investment Gain Loss Including Equity Method Subsidiaries

RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries

-22000000

usd

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

914000000

usd

ci

Transaction Related Costs

TransactionRelatedCosts

7000000

usd

ci

Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

4330000000

usd

CY2024Q2

us-gaap

Premiums Earned Net

PremiumsEarnedNet

11454000000

usd

CY2023Q2

us-gaap

Premiums Earned Net

PremiumsEarnedNet

11039000000

usd

us-gaap

Premiums Earned Net

PremiumsEarnedNet

23057000000

usd

us-gaap

Premiums Earned Net

PremiumsEarnedNet

22064000000

usd

CY2024Q2

ci

Non Investment Revenue

NonInvestmentRevenue

60202000000

usd

CY2023Q2

ci

Non Investment Revenue

NonInvestmentRevenue

48308000000

usd

ci

Non Investment Revenue

NonInvestmentRevenue

117167000000

usd

ci

Non Investment Revenue

NonInvestmentRevenue

94548000000

usd

CY2024Q2

ecd

Non Rule10b51 Arr Adopted Flag

NonRule10b51ArrAdoptedFlag

false

CY2024Q2

ecd

Rule10b51 Arr Trmntd Flag

Rule10b51ArrTrmntdFlag

false

CY2024Q2

ecd

Non Rule10b51 Arr Trmntd Flag

NonRule10b51ArrTrmntdFlag

false

Name	View Source	Status
0001739940-24-000028-index-headers.html	Edgar Link	pending
0001739940-24-000028-index.html	Edgar Link	pending
0001739940-24-000028.txt	Edgar Link	pending
0001739940-24-000028-xbrl.zip	Edgar Link	pending
ci-20240630.htm	Edgar Link	pending
ci-20240630.xsd	Edgar Link	pending
ci-20240630_g1.jpg	Edgar Link	pending
exh_311x24q2.htm	Edgar Link	pending
exh_312x24q2.htm	Edgar Link	pending
exh_321x24q2.htm	Edgar Link	pending
exh_322x24q2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
ci-20240630_cal.xml	Edgar Link	unprocessable
ci-20240630_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ci-20240630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ci-20240630_pre.xml	Edgar Link	unprocessable
ci-20240630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CI
Cigna Group Stock $ci

2024 Q3 Form 10-Q Financial Statement

#000173994024000028 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CI Cigna Group Stock $ci

2024 Q3 Form 10-Q Financial Statement

#000173994024000028 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CI
Cigna Group Stock $ci